AGR3/BCMP11 (Human) Recombinant, FITC Conjugated

AGR3/BCMP11 (Human) Recombinant, FITC Conjugated
Product Code: 00530-01-50F
Our Price: $390.00
Please correct the following:

Description

Anterior Gradient 3 (AGR3) is a biomarker for cancer research, and a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.

Features

• Size: 50ug
  Datasheet: PDF



• © Copyright 2024 Aviscera Bioscience, Inc.

  Powered by Volusion

  Go to main site